Title : Oral bioavailability of dabigatran etexilate (Pradaxa(®) ) after co-medication with verapamil in healthy subjects.

Pub. Date : 2013 Apr

PMID : 22946890






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AIM: To investigate the effect of the P-glycoprotein inhibitor verapamil on the pharmacokinetics and pharmacodynamics of dabigatran etexilate (DE). Verapamil ATP binding cassette subfamily B member 1 Homo sapiens
2 CONCLUSION: Verapamil increased DE bioavailability, likely due to inhibition of P-glycoprotein. Verapamil ATP binding cassette subfamily B member 1 Homo sapiens